Lonza to Expand Singapore Facility

Lonza says it will invest SF10 million ($12 million) to expand its biopharmaceutical development services platform in Singapore. Lonza’s development services business offers services used in the development of biomanufacturing processes. The expansion in Singapore will consist of the addition of laboratory space and associated equipment, and will support cell line construction, upstream and downstream process development, and a range of analytical services. Lonza currently offers these services at its Slough, U.K. facility with a limited offering in...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers